Annual Drug Patent Expirations for THALOMID Thalomid is a drug marketed by Bristol-myers and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent expiration for Bristol-myers drug THALOMID appea…
New patent expiration for Bristol-myers drug THALOMID Read Post »
Annual Drug Patent Expirations for OTEZLA Otezla is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent expiration for Amgen Inc drug OTEZLA appeared first on DrugPat…
Annual Drug Patent Expirations for AUVI-Q Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. It is available from three suppliers. There are thirty-one patents…
The post New patent for Kaleo Inc drug AUVI-Q appeared first on DrugPatentW…
This chart shows the drugs with the most patents in Denmark. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Denmark…
Which pharmaceutical drugs have the most drug patents in Denmark? Read Post »
Annual Drug Patent Expirations for CRESEMBA Cresemba is a drug marketed by Astellas and is included in two NDAs. It is available from one supplier. There are three patents protecting…
The post New patent for Astellas drug CRESEMBA appeared first on Dru…
Annual Drug Patent Expirations for XPOVIO Xpovio is a drug marketed by Karyopharm Theraps and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Karyopharm Theraps drug XPOVIO appeared first on D…
Annual Drug Patent Expirations for XOPENEX+HFA Xopenex Hfa is a drug marketed by Lupin and is included in one NDA. It is available from five suppliers. There are two patents…
The post New patent expiration for LUPIN drug XOPENEX HFA appeared first on D…
New patent expiration for LUPIN drug XOPENEX HFA Read Post »
Annual Drug Patent Expirations for EXPAREL Exparel is a drug marketed by Pacira Pharms Inc and is included in one NDA. It is available from one supplier. There are eight…
The post New patent for Pacira Pharms drug EXPAREL appeared first on DrugPatentWa…
This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of the categories for which the…
The post Pharmaceutical companies with the most ‘New Patient Popul…
Pharmaceutical companies with the most ‘New Patient Population’ drugs Read Post »
Annual Drug Patent Expirations for ZEGALOGUE+%28AUTOINJECTOR%29 Zegalogue (autoinjector) is a drug marketed by Zealand Pharma and is included in one NDA. It is available from two suppliers. There is one…
The post New patent for Zealand Pharma drug ZEGA…
New patent for Zealand Pharma drug ZEGALOGUE (AUTOINJECTOR) Read Post »
Get new actionable insights and updates from BiotechBlog
